跳至主要内容
临床试验/NCT01346046
NCT01346046已完成不适用

An Evaluation of a Noninvasive Diabetes Screening Device in Subjects at the TCOYD Diabetes Conference

VeraLight, Inc.1 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
264
试验地点
1
主要终点
Continuing validation of SCOUT DS algorithm

研究概览

简要总结

The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.

详细描述

Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this study is to correct an imbalance in the disease prevalence of the data set used to develop the SCOUT DS diabetes screening algorithm.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 18 years Self-reported diagnosis of type 2 diabetes No Self-reported diagnosis of type 2 diabetes

排除标准

  • Less than 18 years of age
  • Diagnosed with type 1 diabetes
  • Known to be pregnant (Self Reported)
  • Receiving dialysis or having known renal compromise
  • Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm.
  • Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)

结局指标

主要结局

Continuing validation of SCOUT DS algorithm

时间窗: 1 day

Collect SCOUT DS and Hemoglobin A1c measurements of subjects with Type 2 Diabetes

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of SCOUT DS in Subjects With Type 2... | 临床试验